Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II)

ABSTRACT:

ORGANISM(S): Homo Sapiens

TISSUE(S): Cyst Fluid

DISEASE(S): Cancer

PROVIDER: ST000823 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	mwtab	Other

Items per page:

1 - 1 of 1

Similar Datasets

Pancreatic Cyst Fluid Microbiota Profiling

Project description:Enrichment of Oral Microbiota in Early Cystic Precursors to Invasive Pancreatic Cancer

| PRJEB31827 | ENA

Untargeted metabolomics in gastric and colorectal patients - preliminary results

Project description:The study concerns untargeted metabolomics in gastric and colorectal cancer patients. It was analyzed using mass spectrometry.

2024-05-01 | PXD051921 | Pride

Proteomic profiling of pancreatic cyst fluid in patients with pancreatic cystic lesions identifies novel biomarkers of pancreatic cancer risk

Project description:Pancreatic Cancer (PC) has the worst 5-year survival rate of any cancer as of 2024, at just 13%. The late-stage diagnosis of these patients limits their treatment options, further compounding the problem. Early detection of PC, therefore, is the primary concern of most PC research, as it has the potential to make a substantial difference to the treatment and survival of these patients. Pancreatic cystic lesions (PCLs) are fluid-filled sacs, on or inside the pancreas, that have the potential to become premalignant. While some PCLs are completely benign, others have been shown to have malignant potential and could therefore play a role in the progression to PC. Using the 2018 European evidence-based guidelines for pancreatic cystic neoplasms, patients were classified as being either at a low- or high-risk of PC development. In this study, we profile the proteome of pancreatic cyst fluid from low-risk (n=15) and high-risk (n=17) patients with PCLs and identify differentially expressed proteins between these two risk classifications. We show that these PCF-based differentially expressed proteins have potential utility as biomarkers of risk stratification in this setting.

2025-01-06 | PXD057299 | Pride

Pancreatic fluid

Project description:Microbial Dynamics of Acute Pancreatitis: Integrating Culture, Sequencing, and Bile Impact on Bacterial Populations and Gaseous Metabolites.

| PRJNA1114082 | ENA

N-glycan profiling of Pseudomyxoma peritonei

Project description:Pseudomyxoma peritonei (PMP) is a subtype of mucinous adenocarcinoma of the appendix, We compared N-linked glycan profiles of PMP tissues to those of normal appendix. N-glycosidase F liberated N-glycan profiles of eight normal appendix samples and eight low-grade and eight high-grade PMP specimens were analyzed by MALDI-TOF mass spectrometry. The most prominent alteration was increased and complex fucosylation in high-grade carcinoma. Authors: Lilli Saarinen, Pirjo Nummela, Hannele Leinonen, Annamari Heiskanen, Alexandra Thiel, Caj Haglund, Anna Lepistö, Tero Satomaa, Sampsa Hautaniemi, and Ari Ristimäki; from Genome-Scale Biology Research Program, Research Programs Unit, University of Helsinki; Glykos Finland Ltd, Helsinki; Department of Surgery, University of Helsinki and Helsinki University Hospital; Translational Cancer Biology, Research Programs Unit, University of Helsinki; and Department of Pathology, HUSLAB, University of Helsinki and Helsinki University Hospital, Finland.

2018-08-03 | PXD010086 | Pride

Extracellular Vesicles in Luminal Fluid of the Ovine Uterus

Project description:Exosomes/microvesicles (hereafter referred to as extracellular vesicles) were isolated from the ULF of day 14 cyclic and pregnant ewes using ExoQuick-TC. Extracellular vesicle RNA was pooled (n=4 per status) and analyzed for small RNAs by sequencing on the Ion Torrent PGM platform and analysis with CLC Genomics Workbench small RNA workflow based on the miRBase (Release 19) Bos taurus database. Small RNA analysis of day 14 uterine luminal fluid extracellular vesicles isolated from pregnant and cyclic ewes.

2014-01-11 | E-GEOD-53974 | biostudies-arrayexpress

Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm

Project description: Not available

| ST000713 | MetabolomicsWorkbench

Spatial multi-omics in skeletal muscle unravel complex myofiber architecture

Project description:Spatial distribution of metabolites and phospholipids in murine tibialis anterior (TA) muscles.

2024-09-27 | PXD048809 | Pride

Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer.

Project description: Not available

| S-EPMC8120597 | biostudies-literature

Proteomic profiling reveals potential plasmatic biomarkers for pancreatic adenocarcinoma in Brazilian patients

Project description:Pancreatic cancer is one of the most lethal cancer types worldwide, with the majority of the diagnostics being pancreatic adenocarcinomas (PDAC). Early and accurate diagnosis are among the best alternatives to improve treatment effectiveness and survival of PDCA patients; however, plasmatic biomarkers molecules are scarce. Here, we describe a proteomic screening on depleted plasma from 29 PDAC patients and 30 healthy controls, aiming to identify potential biomarkers for PDAC diagnosis. We observed 121 differentially expressed proteins (DEPs), which were associated with the tumor biology and clinical behavior. We emphasize the potential of three over-expressed proteins (ORM1, ORM2, and SERPINA1), and four down-expressed proteins (ALDOA, PPIA, VCL, and SPARC) as biomarkers in PDAC, which were also correlated with disease staging. It was also demonstrated that some proteins could be used as complementary biomarkers associated with gold-standard CA19-9. Our high throughput proteomics approach suggests a set of proteins with potential use in PDAC diagnosis, giving light to future validation and application in clinical practice, enabling target proteomics and other serological assays.

2025-10-24 | PXD064439 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data